Burgul Cancer Institute Offers First Precision Treatment for Advanced Breast Cancer
For the first time globally, Burjeel Oncology Institute in Abu Dhabi is offering the treatment of "Kamistrastant" for advanced breast cancer, utilizing circulating tumor DNA (ctDNA) testing to enable early detection of resistance to hormone therapy. This treatment is provided to patients with a genetic mutation in the ESR1 gene and helps to control the disease, delay its progression, and improve patients' quality of life. This achievement reflects Abu Dhabi's status as a leading center for precision medicine and specialized healthcare.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)